Back to dataset
UK Inflammatory Bowel Disease (IBD) audit: Round 4 (2012 - 2014)Paediatric biological therapies data - IBD audit 2014
You're previewing the first 4 rows of this file.
Download this file| Health board / Trust name | Sitename | Number of patients with Crohn's disease entered at your site | Number of Crohn's disease follow-up treatments after initial infusion | Response to treatment | Remission achieved | Patients with Crohn's disease treated with Infliximab appropriately prescribed in compliance with NICE criterion1.5 (TA187) | Number of Crohn's disease patients with PROM data completed at initial treatment | Number of Crohn's disease patients with PROM data completed at follow-up treatment | |
|---|---|---|---|---|---|---|---|---|---|
| Alder Hey Childrens NHS Foundation Trust | Alder Hey Childrens Hospital | 46 | 173 | 14/15 (93%) | 12/15 (80%) | 1/31 (3%) | 28/48 (58%) | 11/173 (6%) | Not set |
| Barts Health NHS Trust | Barts and The London Childrens Hospital | 16 | N=0 | N=0 | N=0 | N=0 | 0/16 (0%) | N=0 | Not set |
| Birmingham Childrens Hospital NHS Foundation Trust | Birmingham Childrens Hospital | 59 | 448 | N<6 | N<6 | 1/10 (10%) | 0/59 (0%) | 0/448 (0%) | Not set |
| Cambridge University Hospitals NHS Foundation Trust | Addenbrookes Hospital (paediatric gastro unit) | 19 | 141 | 6/8 (75%) | 5/10 (50%) | 2/13 (15%) | 0/19 (0%) | 0/141 (0%) | Not set |